In 2021, the FDA criticised MSD for relying on an early endpoint to seek approval for Keytruda in early-stage TNBC.

We look forward to the European Commission’s decisions.” "EMA CHMP recommends MSD’s KEYTRUDA for gynaecological cancers" was ...

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.

The approval for the KEYTRUDA regimen is supported by results from the Phase II/III IND.227/KEYNOTE-483 trial.

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

While immunotherapies like Keytruda have transformed the treatment of certain cancers ... PESG Research is a digital commentary brand, offering coverage and exploration into companies and sectors in ...

While immunotherapies like Keytruda have transformed the treatment ... PESG Research is a digital commentary brand, offering coverage and exploration into companies and sectors in the fields ...

The FDA approves subcutaneous formulation of RHHBY's leading immunotherapy drug, Tecentriq, under the brand name Tecentriq ...

Merck's vast pipeline, particularly in oncology, should also deliver many more brand-new medicines moving forward. Though its sales will almost certainly decline once Keytruda's patent expires ...

Pharmac estimates 1000 more people will access these treatments in the first year of funding, and 4500 in the first five years.

Three Fool.com contributors were asked to recommend some no-brainer dividend stocks to buy in September. They selected healthcare companies AbbVie (NYSE: ABBV), Merck (NYSE: MRK), and Pfizer (NYSE: ...

And when I look at KEYTRUDA back in 2019, internationally ... So really excited with sotatercept, WINREVAIR is its brand name. We received the approval. We're launching in Germany and Austria as we ...